ST 045849 New
Chemical Name: 2-[(4-Chlorophenyl)imino]tetrahydro-4-oxo-3-(2-tricyclo[22.214.171.124,7]dec-1-ylethyl)-2H-1,3-thiazine-6-carboxylic acid
Biological ActivityO-GlcNAc transferase (OGT) inhibitor (IC50 = 53 μM). Reduces proliferation and viability of prostate cancer cells in vitro. Depletes intracellular alanine and decreases glucose consumption by cancer cells. Decreases markers of ER stress and apoptosis in pregnant diabetic mice and reduces neural tube defects in embryos from diabetic mice.
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.
Itkonen et al.
Impact of protein O-GlcNAcylation on neural tube malformation in diabetic embryopathy.
Kim et al.
Versatile O-GlcNAc transferase assay for high-throughput identification of enzyme variants, substrates, and inhibitors.
Kim et al.
No product specific FAQs exist for this product, however you mayView all Small Molecule FAQs
Reviews for ST 045849
There are currently no reviews for this product. Be the first to review ST 045849 and earn rewards!
Have you used ST 045849?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image